Itching is often the most debilitating cutaneous symptom of CKD and ESRD. Experts recommend a stepwise treatment approach ...

Antibody-drug conjugates offer targeted power but come with distinct side effects. Learn how clinicians are tackling toxicity ...

Kisunla’s active substance is donanemab, a monoclonal antibody that targets and clears amyloid-beta plaques in the brain, a ...

Massachusetts General in Boston and McLean Hospital in Belmont, Massachusetts, remain the top-ranked hospitals for psychiatry ...

The FDA says synthetic, concentrated 7-hydroxymitragyine, a potent metabolite of kratom, is an opioid and should be ...

How three physicians’ own weight struggles reshape patient care, challenge bias, and push systemic change in treating obesity ...

Aspergillus fumigatus is developing greater resistance to its first-line treatment, and many patients are infected with ...

The adoption of the new “clinical obesity” definition alters prevalence estimates of obesity in many parts of the world ...

From 2016 to 2022, opioid prescribing for low back pain in EDs has declined, but radiograph use has remained high, especially ...

Previous research has shown that HIV-specific CD8 T-cell responses directed against five genetically conserved HIV-1 protein ...

A digital asthma self-management program improves asthma control in adults, with greater benefits observed in non-African ...

Private-equity (PE) acquisition of gastroenterology (GI) practices led to higher colonoscopy prices, utilization, and ...